Astellas drops CV Therapeutics bid (Dealscape

Japanese drugmaker Astellas Pharma Inc. abandoned its $1.1 billion hostile bid for CV Therapeutics Inc. on Monday after the target reached a deal with rival Gilead Sciences Inc.

Astellas decided to withdraw its $16-per-share tender offer after CV agreed to Gilead's $20 per share, or $1.4 billion, takeover on March 12, Tokyo-based Astellas said in a statement.

This is a free preview of the content available in The Deal Pipeline. Subscribers enjoy access to the full story, as well as second-to-none research tools.

To request a demo, or, if you are an existing user to The Deal Pipeline, log in to your account, please scroll down and click the button.

Dig deeper, with Pipeline.

569 company pages related to Pharmaceuticals
73 in-depth reports of withdrawn M&A deals in the Healthcare sector
33 articles related to Astellas Pharma Inc.
19 articles related to CV Therapeutics Inc.
10 years of news and analysis archives from the voice of The Deal Economy

Most searched keywords

Deutsche Bank
Skadden Arps
IMS
Cadbury
Antitrust
Hyatt Corp.
Evercore
Scripps
CIT
Agrium Inc.

Forward-looking intelligence allows you time to act. View this video on our restructuring content to see how you can benefit from our expertise.
NOT A SUBSCRIBER? Astellas drops CV Therapeutics bid Posted on March 16, 2009 4:30 PM Japanese drugmaker Astellas Pharma Inc. abandoned its $1.1 billion hostile bid for CV Therapeutics Inc. on Monday after the target reached a deal with rival Gilead Sciences Inc. Astellas decided to withdraw its $16-per-share tender offer after CV agreed to Gilead's $20 per share, or $1.4 billion, takeover on March 12, Tokyo-based Astellas said in a statement. This is a free preview of the content available in The Deal Pipeline. Subscribers enjoy access to the full story, as well as second-to-none research tools. To request a demo, or, if you are an existing user to The Deal Pipeline, log in to your account, please scroll down and click the button. Dig deeper, with Pipeline. 569 company pages related to Pharmaceuticals 73 in-depth reports of withdrawn M&A deals in the Healthcare sector 33 articles related to Astellas Pharma Inc. 19 articles related to CV Therapeutics Inc. 10 years of news and analysis archives from the voice of The Deal Economy Most searched keywords Deutsche Bank Skadden Arps IMS Cadbury Antitrust Hyatt Corp. Evercore Scripps CIT Agrium Inc.		EXISTING USERS Username Password Forget your password? Missing a product?

Sales Contact Michael Crosby mcrosby@thedeal.com 212.313.9325	Media Contact Martha Brown mbrown@thedeal.com 212.313.9218
Signing in signifies that you agree to our terms and conditions. View our privacy policy.